638-58-4

Basic information

• Product Name: N-TETRADECANAMIDE
• Synonyms: TETRADECANAMIDE;MYRISTAMIDE;MYRISTICAMIDE;N-TETRADECANAMIDE;Myristic acid amide;tetradecanoicacidamide;Tetradecylamide
• CAS NO: 638-58-4
• Molecular Formula: C₁₄H₂₉NO
• Molecular Weight: 227.39
• EINECS: 211-343-2
• Mol File: 638-58-4.mol
• Article Data: 18

Chemical Properties

• Melting Point: 105-107°C
• Boiling Point: 369.11°C (rough estimate)
• Flash Point: 174.1°C
• Appearance: /
• Density: 0.9035 (rough estimate)
• Vapor Pressure: 1.71E-05mmHg at 25°C
• Refractive Index: 1.4640 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 16.61±0.40(Predicted)
• CAS DataBase Reference: N-TETRADECANAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N-TETRADECANAMIDE(638-58-4)
• EPA Substance Registry System: N-TETRADECANAMIDE(638-58-4)

Safety Data

• TSCA: Yes
• Hazardous Substances Data: 638-58-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C14H29NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H2,15,16)

Upstream product

• 544-63-8 n-tetradecanoic acid 
• 112-64-1 tetradecanoyl chloride 
• 112-80-1 cis-Octadecenoic acid 
• 7664-41-7 ammonia 
• 2016-42-4 tetradecylamine 
• 555-45-3 tritetradecanoylglycerol 
• 110-27-0 Tetradecanoic acid 1-methylethyl ester 
• 31161-71-4 benzyl Myristate 
• 7438-09-7 N-methyltetradecanamide 
• 91083-86-2 N-Ethyl-N-nitrosomyristamide 
• 16514-82-2 N-Methyl-N-nitrosomyristamide 
• 124-06-1 Ethyl myristate 
• 91084-04-7 N-ethyltetradecanamide 
• 1120-36-1 1-tetradecene 

Downstream Products

• 101453-46-7 N-hydroxymethyl-myristamide 
• 2869-34-3 1-tridecanamine 
• 2016-42-4 tetradecylamine 
• 629-63-0 myristonitrile 
• 101453-39-8 tridecyl-carbamic acid methyl ester 
• 17361-44-3 ditetradecylamine 
• 1039559-65-3 C₂₈H₄₉NO₂Si 
• 7438-09-7 N-methyltetradecanamide 
• 124-25-4 myristylaldehyde 
• 116749-30-5 tridecylammonium p-toluenesulfonate 

Relevant articles and documents

Selective Transformations of Triglycerides into Fatty Amines, Amides, and Nitriles by using Heterogeneous Catalysis

The use of triglycerides as an important class of biomass is an effective strategy to realize a more sustainable society. Herein, three heterogeneous catalytic methods are reported for the selective one-pot transformation of triglycerides into value-added chemicals: i) the reductive amination of triglycerides into fatty amines with aqueous NH3 under H2 promoted by ZrO2-supported Pt clusters; ii) the amidation of triglycerides under gaseous NH3 catalyzed by high-silica H-beta (Hβ) zeolite at 180 °C; iii) the Hβ-promoted synthesis of nitriles from triglycerides and gaseous NH3 at 220 °C. These methods are widely applicable to the transformation of various triglycerides (C4–C18 skeletons) into the corresponding amines, amides, and nitriles.

NUCLEOSIDE-MODIFIED RNA FOR INDUCING AN ADAPTIVE IMMUNE RESPONSE

The present invention generally relates to compositions and methods for inducing an adaptive immune response in a subject. In certain embodiments, the present invention provides a composition comprising a nucleoside-modified nucleic acid molecule encoding an antigen, adjuvant, or a combination thereof. For example, in certain embodiments, the composition comprises a vaccine comprising a nucleoside-modified nucleic acid molecule encoding an antigen, adjuvant, or a combination thereof.

Metal-Free Thermal Activation of Molecular Oxygen Enabled Direct α-CH2-Oxygenation of Free Amines

Direct oxidation of α-CH2 group of free amines is hard to achieve due to the higher reactivity of amine moiety. Therefore, oxidation of amines involves the use of sophisticated metallic reagents/catalyst in the presence or absence of hazardous oxidants under sensitive reaction conditions. A novel method for direct C-H oxygenation of aliphatic amines through a metal-free activation of molecular oxygen has been developed. Both activated and unactivated free amines were oxygenated efficiently to provide a wide variety of amides (primary, secondary) and lactams under operationally simple conditions without the aid of metallic reagents and toxic oxidants. The method has been applied to the synthesis of highly functionalized amide-containing medicinal drugs, such as O-Me-alibendol and -buclosamide.